"Mice, Transgenic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Laboratory mice that have been produced from a genetically manipulated EGG or EMBRYO, MAMMALIAN.
| Descriptor ID |
D008822
|
| MeSH Number(s) |
B01.050.050.136.500 B01.050.150.900.649.313.992.635.505.500.800
|
| Concept/Terms |
Mice, Transgenic- Mice, Transgenic
- Mouse, Transgenic
- Transgenic Mouse
- Transgenic Mice
Founder Mice, Transgenic- Founder Mice, Transgenic
- Mice, Transgenic Founder
- Transgenic Founder Mice
- Mouse, Founder, Transgenic
|
Below are MeSH descriptors whose meaning is more general than "Mice, Transgenic".
Below are MeSH descriptors whose meaning is more specific than "Mice, Transgenic".
This graph shows the total number of publications written about "Mice, Transgenic" by people in this website by year, and whether "Mice, Transgenic" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 2 | 2 |
| 1998 | 0 | 1 | 1 |
| 1999 | 0 | 1 | 1 |
| 2000 | 0 | 2 | 2 |
| 2001 | 0 | 2 | 2 |
| 2003 | 0 | 4 | 4 |
| 2004 | 0 | 3 | 3 |
| 2005 | 0 | 9 | 9 |
| 2006 | 0 | 9 | 9 |
| 2007 | 1 | 5 | 6 |
| 2008 | 0 | 4 | 4 |
| 2009 | 0 | 4 | 4 |
| 2010 | 0 | 5 | 5 |
| 2011 | 0 | 7 | 7 |
| 2012 | 1 | 6 | 7 |
| 2013 | 1 | 10 | 11 |
| 2014 | 0 | 8 | 8 |
| 2015 | 0 | 9 | 9 |
| 2016 | 0 | 15 | 15 |
| 2017 | 0 | 173 | 173 |
| 2018 | 3 | 127 | 130 |
| 2019 | 1 | 41 | 42 |
| 2020 | 3 | 23 | 26 |
| 2021 | 0 | 45 | 45 |
To return to the timeline, click here.
Below are the most recent publications written about "Mice, Transgenic" by people in Profiles.
-
H1N1 exposure during the convalescent stage of SARS-CoV-2 infection results in enhanced lung pathologic damage in hACE2 transgenic mice. Emerg Microbes Infect. 2021 Dec; 10(1):1156-1168.
-
Highly susceptible SARS-CoV-2 model in CAG promoter-driven hACE2-transgenic mice. JCI Insight. 2021 10 08; 6(19).
-
S100A8 may govern hyper-inflammation in severe COVID-19. FASEB J. 2021 09; 35(9):e21798.
-
ACE2-targeting monoclonal antibody as potent and broad-spectrum coronavirus blocker. Signal Transduct Target Ther. 2021 08 25; 6(1):315.
-
The neutralization potency of anti-SARS-CoV-2 therapeutic human monoclonal antibodies is retained against viral variants. Cell Rep. 2021 09 07; 36(10):109679.
-
Protective Effects of Astodrimer Sodium 1% Nasal Spray Formulation against SARS-CoV-2 Nasal Challenge in K18-hACE2 Mice. Viruses. 2021 08 20; 13(8).
-
Live imaging of SARS-CoV-2 infection in mice reveals that neutralizing antibodies require Fc function for optimal efficacy. Immunity. 2021 09 14; 54(9):2143-2158.e15.
-
Mild and Severe SARS-CoV-2 Infection Induces Respiratory and Intestinal Microbiome Changes in the K18-hACE2 Transgenic Mouse Model. Microbiol Spectr. 2021 09 03; 9(1):e0053621.
-
In Vivo protection from SARS-CoV-2 infection by ATN-161 in k18-hACE2 transgenic mice. Life Sci. 2021 Nov 01; 284:119881.
-
Contribution of SARS-CoV-2 Accessory Proteins to Viral Pathogenicity in K18 Human ACE2 Transgenic Mice. J Virol. 2021 08 10; 95(17):e0040221.